Correlation Between Biovaxys Technology and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Biovaxys Technology and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biovaxys Technology and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biovaxys Technology Corp and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Biovaxys Technology and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biovaxys Technology with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biovaxys Technology and Rigel Pharmaceuticals.
Diversification Opportunities for Biovaxys Technology and Rigel Pharmaceuticals
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Biovaxys and Rigel is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Biovaxys Technology Corp and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Biovaxys Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biovaxys Technology Corp are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Biovaxys Technology i.e., Biovaxys Technology and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Biovaxys Technology and Rigel Pharmaceuticals
Assuming the 90 days horizon Biovaxys Technology Corp is expected to under-perform the Rigel Pharmaceuticals. But the otc stock apears to be less risky and, when comparing its historical volatility, Biovaxys Technology Corp is 2.15 times less risky than Rigel Pharmaceuticals. The otc stock trades about -0.05 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest 1,420 in Rigel Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 1,341 from holding Rigel Pharmaceuticals or generate 94.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biovaxys Technology Corp vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Biovaxys Technology Corp |
| Rigel Pharmaceuticals |
Biovaxys Technology and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biovaxys Technology and Rigel Pharmaceuticals
The main advantage of trading using opposite Biovaxys Technology and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biovaxys Technology position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Biovaxys Technology vs. Rigel Pharmaceuticals | Biovaxys Technology vs. Geron | Biovaxys Technology vs. Verastem | Biovaxys Technology vs. Immutep Ltd ADR |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |